Table 2.
Author and Year | Patients | Dosage of Vitamin C | p.o./i.v. | Results |
---|---|---|---|---|
Knodell 1981 [157] | 175+ hepatitis | Preop: 4 × 800 mg/day for 2 days | p.o. | Elevations of plasma vitamin C, no influence on the hepatitis |
Postop: 4 × 800 mg/day for 2 weeks | ||||
Li 1990 [158] | 20 | Preop: 250 mg/kg before the start of extracorporeal circulation | N.A. | Sign. reduction in lipid peroxidation |
Dingchao 1994 [86] | 85 CPB | 125 mg/kg 30 min before surgery and at the end of CPB | i.v. | Decreased CK/CKMB, LDH, & rate of defibrillation, ICU- and hospital LOS, improved CI |
Carnes 2001 [159] | 86 CABG | Preop: 1 × 2 g the night before | N.A. | Lower rate of AF |
Postop: 2 × 0.5 g/day for 5 days | ||||
Demirag 2001 [160] | 30 elective | Group 1: 2 × 50 mg/kg vitamin C at induction and end of CPB | i.v. | Prevention of lipid peroxidation no difference in myocardial I/R-injury |
Group 2: vitamin C + diltiazem: bolus and 2 µg/kg/min until end of CPB | ||||
Eslami 2007 [161] | 100 CABG | Preop: 1 × 2 g night before | p.o. | Lower rate of AF |
Postop: 2 × 1 g/day for 5 days | ||||
Colby 2011 [162] | 24 CABG and/or valve | Preop: 1 × 2 g night before | p.o. | No difference in CRP, WBC, fibrinogen, Trend: decreased AF, hospital- and ICU-LOS |
Postop: 2 × 0.5 g/day for 4 days | ||||
Papoulidis 2011 [163] | 170 CABG | Preop: 1 × 2 g 3 h prior to surgery | i.v. | Sign. lower rate of AF, hospital- and ICU-LOS |
Postop: 2 × 0.5 mg/day for 5 days | ||||
Bjordahl 2012 [164] | 185 CABG | Preop: 1 × 2 g night before surgery | p.o. | No difference in postoperative complications, mortality or AF |
Postop: 2 × 1 g/day for 5 days | ||||
Jouybar 2012 [156] | 40 CABG | Preop: 2 × 3 g 12–18 h before surgery and during CPB initiation | i.v. | No difference in inflammatory cytokines, hemodynamics, blood gases, urea nitrogen, creatinine, WBC, platelet counts & outcomes |
Dehghani 2014 [165] | 100 CABG | Preop: 1 × 2 g | p.o. | Sign. lower rate of AF, hospital- and ICU-LOS |
Postop: 2 × 0.5 g/day for 5 days | ||||
Ebade 2014 [166] | 40 | Preop: 1 × 2 g | i.v. | Lower incidence of AF |
Postop: 1 × 1 g 12 h after surgery, 3 × 1 g for 6 days after surgery | Shortened ICU- and hospital-LOS | |||
Sama-dikhah 2014 [167] | 120 CABG | Preop: 1 × 2 g | p.o. | Sign. lower rate of AF |
Postop: 1 × 1 g/day for 5 days | ||||
Plus atorvastatin 40 mg | ||||
Sadegh-pour 2015 [141] | 290 CABG, valve | Preop: 1 × 2 g before surgery | Preop: i.v. Postop: p.o. | Sign. reductions in AF, hospital-LOS, intubation time, complications (death, renal function, infection) and drainage, unchanged ICU-LOS |
Postop: 1 × 1 g/day for 4 days | ||||
Das 2016 [168] | 70 elective low risk CABG | Preop: 2 × 0.5 g for 7 days prior to surgery | p.o. | Lower vasopressors-demand, no difference in time to extubation, ICU- and hospital-LOS, mortality or complications |
Antonic 2016 [169] | 105 CABG | Preop: 2 × 2 g: 24 and 2 h before surgery | i.v. | Trend: decreased rate of AF, no difference in complications |
Postop: 2 × 1 g/day for 4 days | ||||
Antonic 2017 [119] | 100 CABG | Preop: 2 × 2 g: 24 and 2 h | i.v. | No sign. protective effect of ascorbic acid on the incidence of postoperative AKI |
Postop: 2 × 1 g/day for 5 days |
CPB = cardiopulmonary bypass, CABG = coronary artery bypass graft, p.o. = per os, i.v. = intravenous, sign. = significantly, N.A. = not available, WBC = white blood count, preop = before surgery, postop = after surgery, LDH = lactate dehydrogenase.